Osaic Holdings
ACRS icon

Osaic Holdings’s Aclaris Therapeutics ACRS Stock Holding History

Osaic Holdings’s Portfolio ACRS Stock Details ACRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-730
Closed -$2.2K – 7801
2025
Q4 		$2.2K Hold
730
– – ﹤0.01% 7064
2025
Q3 		$1.4K Hold
730
– – ﹤0.01% 7247
2025
Q2 		$1.04K Sell
730
-740
-50% -$1K ﹤0.01% 7137
2025
Q1 		$2.25K Sell
1,470
-1,212
-45% -$2.58K ﹤0.01% 6544
2024
Q4 		$6.65K Buy
2,682
+950
+55% +$2.36K ﹤0.01% 6034
2024
Q3 		$1.99K Buy
+1,732
New +$2.12K ﹤0.01% 6615
2024
Q2 		– Sell
-124
Closed -$154 – 7390
2024
Q1 		$154 Buy
+124
New +$148 ﹤0.01% 6995
2023
Q4 		– Sell
-33
Closed -$226 – 7284
2023
Q3 		$226 Buy
33
+17
+106% +$145 ﹤0.01% 7131
2023
Q2 		$166 Hold
16
– – ﹤0.01% 7235
2023
Q1 		$129 Buy
+16
New +$203 ﹤0.01% 7309
2021
Q3 		– Sell
-3,195
Closed -$56K – 7155
2021
Q2 		$56K Buy
3,195
+300
+10% +$6.82K ﹤0.01% 4954
2021
Q1 		$73K Sell
2,895
-1,105
-28% -$21.6K ﹤0.01% 4588
2020
Q4 		$26K Hold
4,000
– – ﹤0.01% 4990
2020
Q3 		$10K Sell
4,000
-1,000
-20% -$2.24K ﹤0.01% 5248
2020
Q2 		$8K Hold
5,000
– – ﹤0.01% 5265
2020
Q1 		$5K Buy
+5,000
New +$6.81K ﹤0.01% 5309

Other funds holding ACRS

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Osaic Holdings's ACRS Position: Q1 2026 in Review

Osaic Holdings sold out of Aclaris Therapeutics (ACRS) in Q1 2026, closing a stake of 730 shares — an estimated $2.2K sold.

Osaic Holdings first reported a position in ACRS in Q1 2020 and held it in 16 quarters. The position peaked at $73K in Q1 2021. 136 funds tracked by Wall St. Rank hold ACRS as of Q1 2026.

  • Osaic Holdings reported no remaining Aclaris Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Osaic Holdings sold 730 Aclaris Therapeutics shares in Q1 2026, an estimated $2.2K.
  • Osaic Holdings first reported a position in Aclaris Therapeutics in Q1 2020 and held it in 16 quarters.
  • Osaic Holdings's Aclaris Therapeutics position peaked at $73K in Q1 2021.
  • 136 funds tracked by Wall St. Rank held Aclaris Therapeutics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.